Why the study?
The relationship between HDL-C and intensive blood pressure control across specific cardiovascular events had never been investigated in patients with hypertension.
Do high HDL-C levels reduce the risk of composite cardiovascular outcomes in patients with hypertension compared to low HDL-C levels?
Cohort (n=9,323)
Yes
Do high HDL-C levels reduce the risk of composite cardiovascular outcomes in patients with hypertension compared to low HDL-C levels?
Hazard Ratio: 0.45 (95% CI 0.21–0.93)
Absolute Event Rate: 4.84% vs 10.53%
p-value: p=0.0301
In hypertensive patients without diabetes, there is an L-shaped association between HDL-C levels and composite cardiovascular events, with very high HDL-C (>80 mg/dL) predicting lower cardiovascular risk in men but not women.
Previous studies in patients with hypertension have demonstrated that there is a U-shaped association between HDL-C (high-density lipoprotein cholesterol) and the risk of cardiovascular events in male patients with hypertension. However, to the best of our knowledge, the relationship between HDL-C and intensive blood pressure control in specific cardiovascular events has never been investigated. To fill this knowledge gap, the authors analyzed the relationship between HDL-C levels and cardiovascular events in hypertensive patients within the Systolic Blood Pressure Intervention Trial (SPRINT). The SPRINT evaluated the impact of intensive blood pressure control (systolic blood pressure < 120 mm Hg) versus standard blood pressure control (systolic blood pressure < 140 mm Hg). The Cox proportional risk regression was used to investigate the association between different HDL-C status and clinical outcomes. Additional stratified analyzes were performed to evaluate the robustness of sex difference. A total of 9323 participants (6016 [64.53%] males and 3307 [35.47%] females) with hypertension from the SPRINT research were included in the analysis. The median follow-up period was 3.26 years. Our population was divided into five groups based on the HDL-C plasma levels: HDL-C < 30 mg/dL, HDL-C between 30 and 40 mg/dL, HDL-C between 40 and 60 mg/dL, HDL-C between 60 and 80 mg/dL and HDL-C > 80 mg/dL. Sensitivity analyzes showed that in the SPRINT, women in the HDL-C high population had a higher risk of mortality from all causes than men. In this cohort study, results suggest that patients with HDL-C levels higher than 80 mg/dL had lower risk of SPRINT primary outcome, cardiovascular death, and stroke, but this study tested association, not causation. HDL-C levels were associated with composite cardiovascular outcomes in male but not female patients. Our results demonstrated that in patients with hypertension, the association between HDL-C and risk of cardiovascular events is L-shaped.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) conducted a cohort in Hypertension (n=9,323). HDL-C > 80 mg/dL vs. HDL-C ≤ 30 mg/dL was evaluated on Composite of myocardial infarction, non-MI acute coronary syndrome, new-onset stroke, heart failure, and death attributable to CVD (HR 0.45, 95% CI 0.21-0.93, p=0.0301).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: